摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry and relates to hard, suitable for oral intake pharmaceutical forms of application with modified release, which contain 5-chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morphoilinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamide, as well as to method of their obtaining, their application as medication, their application for prevention, secondary prevention and/or treatment of diseases, mediated by blood coagulation factor Xa. ^ EFFECT: permanent concentration of active substance of the blood. ^ 19 cl, 10 ex |